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Abstract
Background: The synthesis of the neurotransmitters serotonin (5-HT) and dopamine (DA) in the brain can be
directly altered by dietary manipulation of their relevant precursor amino acids (AA). There is evidence that
altered serotonergic and dopaminergic neurotransmission are both associated with impaired attentional
control. Specifically, phasic alertness is one specific aspect of attention that has been linked to changes in
5-HT and DA availability in different neurocircuitries related to attentional processes. The present study
investigated the impact of short-term reductions in central nervous system 5-HT and DA synthesis, which was
achieved by dietary depletion of the relevant precursor AA, on phasic alertness in healthy adult volunteers;
body weightadapted dietary tryptophan and phenylalaninetyrosine depletion (PTD) techniques were used.
Methods: The study employed a double-blind between-subject design. Fifty healthy male and female subjects
were allocated to three groups in a randomized and counterbalanced manner and received three different
dietary challenge conditions: acute tryptophan depletion (ATD, for the depletion of 5-HT; N16), PTD (for
the depletion of DA; N17), and a balanced AA load (BAL; N17), which served as a control condition.
Three hours after challenge intake (ATD/PTD/BAL), phasic alertness was assessed using a standardized test
battery for attentional performance (TAP). Blood samples for AA level analyses were obtained at baseline
and 360 min after the challenge intake.
Results: Overall, there were no significant differences in phasic alertness for the different challenge conditions.
Regarding PTD administration, a positive correlation between the reaction times and the DA-related deple-
tion magnitude was detected via the lower plasma tyrosine levels and the slow reaction times of the first run of
the task. In contrast, higher tryptophan concentrations were associated with slower reaction times in the
fourth run of the task in the same challenge group.
Conclusion: The present study is the first to demonstrate preliminary data that support an association
between decreased central nervous system DA synthesis, which was achieved by dietary depletion strategies,
and slower reaction times in specific runs of a task designed to assess phasic alertness in healthy adult
volunteers; these findings are consistent with previous evidence that links phasic alertness with dopaminergic
neurotransmission. A lack of significant differences between the three groups could be due to compensatory
mechanisms and the limited sample size, as well as the dietary challenge procedures administered to healthy
participants and the strict exclusion criteria used. The potential underlying neurochemical processes related to
phasic alertness should be the subject of further investigations.
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A
ttention is one of the most widely studied topics
within the experimental and clinical neuros-
ciences. Regarding the underlying neurobiologi-
cal and neurochemical properties, attentional processes
have been linked to changes in central nervous dopami-
nergic (DA) and serotonergic (5-HT) neurotransmission.
Of note, the central nervous system availability of these
particular neurotransmitters can be manipulated by chang-
ing the intake of their respective precursor amino acids
(AA) using dietary depletion strategies (112); this approach
enables short-term manipulations of these neurotrans-
mitters within experimental settings. As a consequence,
the assessment of attentional performance after dietary
depletion of central nervous system DA and 5-HT syn-
thesis enables conclusions to be drawn regarding the
impact of these neurotransmitters on different aspects of
attention.
Current evidence suggests that the attention system in
humans consists of various anatomical networks, which
are specified into different functions (13), and must be dif-
ferentiated from processing systems, which are responsible
for memory storage, decision-making and problem-solving
activities (14). Posner and Petersen (15) described three
different networks that comprised the attention system:
orienting, executive, and alerting. The main task of the
orienting network is to prioritize all sensory inputs. When
processing information, a selection for a modality or a
location occurs. The executive network is primarily in-
volved in target detection. Different targets can be moni-
tored at the same time; however, the moment of detection
causes interferences, which lead to a slower detection of
other stimuli (16). Alertness, which is the subject of the
present study, can be subdivided into two domains, tonic
and phasic. Tonic alertness is described as a particular
form of vigilance. In contrast, phasic alertness is required
to be prepared for an expected stimulus. The performance
is better if a warning signal, such as a cued stimulus, is
provided, depending on the interval between the warning
signal and signal detection (17).
The anatomical correlates of alertness include a variety
of different brain regions. The dorso-lateral prefrontal
cortex (DLPFC) exhibits activation during phasic alert-
ness tasks that are characterized by the use of a warning
signal (18). Another region, which is of particular im-
portance in the context of alertness and attention, is the
anterior cingulate cortex (ACC) (19); the ACC is rich
in dopaminergic projections and plays a critical role
in attentional processes. Research has identified ACC
dysfunctions in attention deficit hyperactivity disorder
(ADHD), which is a neuropsychiatric disorder character-
ized by inattention, impulsiveness, and hyperactivity (20).
PET and fMRI studies have identified activations in the
frontal, parietal, thalamic, and brain-stem networks and
have primarily demonstrated the right hemisphere to be
involved in phasic alertness tasks (21).
The normal function of the alertness network is influ-
enced by many neurotransmitters with complex interac-
tions, including transport mechanisms and degradation
pathways. The central nervous system availability of neu-
rotransmitters that are relevant for attentional processes
(i.e. alertness) include, among others, 5-HT, DA, and
noradrenaline (NE) (4). These particular neurotransmitter
systems can be modulated through a variety of different
mechanisms: polymorphisms in monoamine oxidase A
(MAO-A), one of the most important enzymes in the
brain, and the degradation of biogenic amines (includ-
ing the key neurotransmitters 5-HT, DA, and NE)
significantly influence reaction times in the attention
network test (22). The same effect applies for catechol-
O-methyl-transferase COMT, an enzyme that inactivates
catecholaminergic neurotransmitters and impacts the
dopaminergic signal-to-noise ratio (SNR). The SNR
refers to local cortical microcircuits which are essential
to cortical representation of external and internal stimuli
(23). Moderate DA elevations thereby improve signaling
to a certain extent (24). Furthermore, the perception of
external stimuli is subject to top-down control associated
with the prefrontal cortex, which receives ascending infor-
mation from the major neurotransmitter systems, such
as DA, 5-HT, acetylcholine (Ach), and noradrenaline
(NA) (25).
The efficiency of the alerting network is primarily
manipulated by NE, whereas the alerting and orienting
networks are thought to be related to cholinergic and DA-
related modulations, with evidence that originates from
research involving pharmacological manipulations (26).
Research on neuropharmacological mechanisms often uses
the strategy of changing the central nervous availability
of neurotransmitters by manipulating the availability of
their relevant precursor AAs, which, in turn, can be
changed by established dietary depletion strategies using
established procedures (212, 2729).
In general, plasma concentrations of AAs are not only
regulated by the amount of food ingested but also by the
composition of macronutrients that determine the ratio of
AAs to each other in plasma, and thus can affect their
availability in the brain through a variety of mechanisms.
Because the underlying enzymes for neurotransmitter
synthesis are not fully saturated, changes in the concen-
trations of the relevant precursor AAs are one possible
mechanism to impact neurotransmitter synthesis. Changes
in the ratio of carbohydrates to proteins ingested can cause
differences in plasma tryptophan and LNAAs ratios.
Meals rich in proteins cause a decrease in the ratio of
plasma tryptophan to LNAAs, in particular as they pro-
vide less TRP than LNAAs and thus facilitate influx of
AAs other than TRP into the brain.
In contrast, insulin secretion after a carbohydrate-
rich meal will likely increase the ratio of plasma TRP
to LNAAs via an increased AA uptake into the liver and
Patricia Hildebrand et al.
2
(page number not for citation purpose)
Citation: Food & Nutrition Research 2015, 59: 26407 - http://dx.doi.org/10.3402/fnr.v59.26407
muscles. In the central nervous system, insulin is involved
in weight control and regulation through the reduction
of energy intake (26). Those two mechanisms (insulin
secretion after carbohydrate intake and AA metabolism
in the liver) are almost balanced if carbohydrates and
proteins are ingested in a ratio of 5:6 (28). The same
applies to changes in tyrosine concentrations. However,
it needs to be mentioned that the effects of tyrosine on
central nervous dopamine synthesis are thought to be less
pronounced than the effects of TRP for brain 5-HT syn-
thesis, the reason for this being related to the activity of
the enzyme tyrosine hydroxylase whose catalytic activity
does not only depend on enzyme saturation but also on
the availability of its cofactor tetrahydrobiopterin (29).
Finally, disorders like premenstrual syndrome, seasonal
depression and affective disorders are characterized by
disturbances in mood and appetite, possibly associated
with craving for carbohydrates. Moreover, research sug-
gests that carbohydrates consumed can increase 5-HT
availability in the brain and can thus impact mood (30).
The present work focuses on phasic alertness and its
neurochemical underpinnings modulated by the neuro-
transmitters 5-HT and DA and the dietary availability of
their respective precursor AAs. Tonic and phasic alert-
ness, which are the two main components of the alertness
construct, are closely related to arousal in humans. As
previously discussed, these neurotransmitter systems are
thought to be related to the attention system in the
human brain. The present study investigates the effects of
diminished central nervous system 5-HT and DA synth-
esis, which was achieved by dietary acute tryptophan
depletion (ATD, which decreases central nervous system
5-HT synthesis) and phenylalaninetyrosine depletion
(PTD, which decreases DA synthesis in the brain), on
phasic alertness in healthy adult volunteers. This research
is of particular importance to gain further understanding
of the underlying mechanisms related to attentional pro-
cesses and to develop novel strategies for interventions in
patients with attentional problems, which potentially use
neurodietary concepts and related approaches. Although
the results of studies that have focused on the effects of
ATD on memory, attention, and executive functions are
somewhat inconsistent, we expected that reduced seroto-
nergic inhibition on monoaminergic and cholinergic systems
would improve attentional control (27, 30). Deficiencies
in attention, memory, and motivational and behavioral
processes have been identified in patients with ADHD,
a neuropsychiatric disorder with an etiology most likely
associated with changes in dopaminergic turnover. The
most common treatment for ADHD is methylphenidate,
which increases extracellular DA in the brain and thereby
reduces impulsiveness and inattentiveness. A correlation
between DA and alterations in attentional processes has
been demonstrated (31); however, mixed findings have
been reported in studies that used PTD or systematic
administration of selective DA receptor agonists and
antagonists. Therefore, we expected that PTD would lead
to impaired attentional control and subsequently slower
reaction times in a phasic alertness task.
Methods
Study sample
In the present study, data from a sample that comprised
50 healthy adult subjects were analyzed. The mean age was
24.794.6 years. Gender within the study sample was
balanced (25 females, 25 males) and almost equally dis-
tributed over the three subgroups with respect to the
depletion of 5-HT (ATD; N16) and DA (PTD; N17)
and the administration of a balanced amino acid load
(BAL; N17), which served as a control condition. The
characteristics of the study sample are shown in Table 1.
The study was assessed and approved by the local ethics
committee and was conducted in accordance with the
Helsinki Declaration. Each subject was provided with a
complete description of the study, and written and verbal
informed consents were obtained prior to participation.
The participants were financially compensated for their
participation.
Only healthy adults without acute or previous psychia-
tric or acute somatic disorders were included (ineligible
individuals were excluded prior to participation via inter-
view and individual history). A screening procedure for
mental disorders (SCID; Structured Clinical Interview
for DSM-IV axis I disorders) was implemented to exclude
DSM-IV Axis I disorders known to be associated with
changes in neurotransmitter systems of the human brain.
This study was part of a larger testing battery that in-
cluded an fMRI-experiment on social decision-making,
which is the subject of a different publication. In addition
to the standard contraindications of an MRI examina-
tion, an IQ below 85, substance abuse and pregnancy
were exclusion criteria. Moreover, the individual BMI of
every subject was calculated as surrogate for possible
Table 1. The characteristics (age in years, weight in kg) of the
different study groups with regard to their distribution over three
groups that received acute tryptophan depletion (ATD, to decrease
central nervous system serotonin synthesis), phenylalaninetyrosine
depletion (PTD, to decrease central nervous system dopamine
synthesis), or a balanced amino acid load (BAL, which served as
a control condition)
Age (years9SD) Weight (kg9SD)
ATD 24.3894.13 71.22913.54
PTD 23.5993.12 70.41911.65
BAL 26.2495.86 74.68917.86
Data are presented as the mean9standard deviation.
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pathological differences in the metabolism of AA. All
subjects came from the same catchment area, and most of
the participants were students of similar educational and
socio-economic background. In this way, the study sample
kept as homogenous as possible to avoid further factors
influencing behavioral and biological testing results.
A body weightadapted dietary depletion procedure
termed Moja-De was used (32). One major advantage of
the body weightadapted dietary depletion procedure is
its improved tolerability, which also enables its use in
children and adolescents (3, 29, 33, 34). In addition, the
Moja-De procedure also considers baseline plasma TRP
concentrations because of a positive correlation between
baseline TRP and body weight (2). Moreover, the ATD
challenge procedure has recently been validated in an
animal model (1) and demonstrated a significant decrease
in TRP influx into the brain following administration in
healthy adults (3). In addition, a recent study demon-
strated that a PTD challenge administration in accor-
dance with body weight affected DA synthesis and
reduced TYR and HVA concentrations in the brain (35).
Study design
A randomized, double-blind, between-subject design was
used (the reason for this was that some of the behavioral
testing batteries administered to the subjects are difficult
to be used in a repeated measures design because of learn-
ing effects; these data are subject to different publications).
The subjects were assigned to three groups in a rando-
mized and counterbalanced manner: dietary depletion
of 5-HT (ATD), depletion of DA (PTD), and a control
group (BAL). Testing was conducted on one study day
for each subject. The present publication focuses on the
behavioral data related to aspects of phasic alertness.
AA administration and the assessment of attentional
performance as indexed by phasic alertness were followed
by an fMRI experiment, which examined aspects of
social decision-making performed 300 min after AA
administration (the data from this experiment are the
subject of a different publication).
Depletion procedure
ATD is a neurodietary method used to achieve a short-
term reduction in central nervous system 5-HT synthesis,
which induces short-term serotonergic dysfunction. This
method enables the examination of the underlying effects
of 5-HT on different behavioral, affective and biological
parameters. 5-HT, which cannot cross the bloodbrain
barrier, must be synthesized in the brain. The essential
AA tryptophan (TRP) serves as the biological precursor
of 5-HT, and TRP must be obtained with daily nutrition
intake. TRP uptake into the brain across the bloodbrain
barrier is mediated by a transport protein called L-1,
which facilitates AA influx across the bloodbrain barrier.
In addition to TRP, L-1 is also utilized by tyrosine
([TYR], which serves as a precursor for DA) and other
large neutral amino acids (LNAAs). As a consequence,
changes in the concentrations of AAs that use L-1 can
impact AA influx and biological precursor availability for
neurotransmitters in the brain. The rate-limiting step in
central nervous system 5-HT synthesis is the hydroxyla-
tion of TRP into 5-hydroxytryptophan, which is con-
trolled by the enzyme tryptophan hydroxylase 2 (TPH-2).
Under physiological conditions, this particular enzyme
is only saturated up to 50%. Thus, dietary changes in phy-
siological 5-HT-related precursor availability (in terms of
TRP) automatically lead to altered enzyme saturations,
which can then lead to changes in the synthesis rate (36).
In ATD, participants are provided a TRP-free mixture
of LNAAs for oral intake. The resulting diminished TRP
influx into the brain is attributed to combined effects:
First, the administered AAs compete with TRP for uptake
into the brain. Second, a stimulated protein biosynthesis
in the liver, where endogenous TRP is consumed and
removes TRP from plasma stores, must also be consid-
ered. Moreover, a passive diffusion of TRP across the
bloodbrain barrier contributes to the overall TRP bal-
ance in the central nervous system. PTD is based on the
same underlying principle as ATD. The corresponding
AA mixtures used for PTD are lacking in the catecho-
lamine precursor phenylalanine (PHE). Although PHE
belongs to the group of essential AAs, it is the lack of
TYR (a dispensable or nonessential AA) that reduces
DA synthesis because of reduced substrate availability
for the key regulatory enzyme in catecholamine synthesis,
tyrosine hydroxylase, which is normally not fully satu-
rated (37). As previously discussed, both DA precursors
use the same transport system as TRP to cross the blood
brain barrier. The saturable L-1 transporter mediates
a competitive, electroneutral facilitated diffusion of the
neutral AAs, which depends on their affinities to the
transporter and their blood concentrations (38).
In the present study, ATD-, PTD-, and BAL-related
AA mixtures were provided and administered. The AA
mixtures were stored in brown wide mouth light absorb-
ing bottles at 88C until use. The quantities of the different
AA mixtures for the three different conditions (ATD,
PTD, and BAL) are shown in Table 2.
All participants were subjected to an overnight fast after
8 pm the day prior to study participation. The participants
were allowed to drink water ad libitum throughout the
respective study day. Prior to administration, the AAs
of the respective challenge conditions were dissolved in
water using a milk frother. Before the AA beverages were
administered, the body weight was verified, as well as a
drug screen; a pregnancy test was administered to female
subjects. The first baseline blood sample was collected
prior to the ingestion of the respective challenge beverage
(T1); the second blood sample was collected approximately
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360 minutes after the challenge intake. The participants
were instructed to ingest the entire beverage in one go, if
possible. Following the oral ingestion of the correspond-
ing AA mixture dissolved within a beverage, the partici-
pants received a standardized, low-protein breakfast.
Subjective mood was assessed on the basis of a
questionnaire (39) at seven different time points through-
out the study day; the assessments began prior to the
first blood sample at baseline, followed by assessments
at hourly intervals and after the MRI scan (T2). The
participants were provided their own room for the entire
study day.
Mood assessment
The ASTS (39), a German version of the ‘Profile of mood
states’ (POMS), is a self-assessment questionnaire that
aims to assess different aspects of mood and subjective
well-being. The areas assessed included grief, despair,
fatigue, positive mood, and anger. The ASTS is a reliable
tool for the subjective assessment of current mood (39).
The mood data are the subject of a different publication.
Assessment of phasic alertness
Three hours after the ingestion of the AA mixtures,
attentional performance was assessed using a neuropsy-
chological test battery for attentional performance (40).
This publication focuses on phasic alertness and the
potential changes in this parameter with regard to the
administration of ATD, PTD and BAL, other aspects of
attentional performance are subject to different publica-
tions. This time point represents the time with sufficient
depletion, which has been demonstrated by research in
humans (3) and rodents (1). To ensure absolute silence
during the assessment of attentional performance, testing
was conducted in the participant’s room without interrup-
tion. The overall testing time for the assessment of pha-
sic alertness was approximately 20 min per participant.
A short training session prior to the final assessment was
administered for each participant. The computerized mea-
surements of attentional performance involved the posi-
tioning of the subjects in a comfortable way. The subjects
were instructed to maintain an approximately one meter
distance between them and the PC screen and to leave their
hand in a calm manner on the response key. No feed-
back regarding individual performance was provided.
The testing conditions were similarly maintained for all
participants.
The task included four blocks, with each consisted
of 20 target stimuli, and the reaction times to a target
stimulus were assessed. Phasic alertness was measured
by the reaction times to a target stimulus preceded by
a signal tone, which followed an ABBA design (A: trial
without a preceding warning signal, B: trial with a pre-
ceding warning signal) and is a standardized procedure
(40). The participants were instructed to react via button-
press as quickly as possible to a cross (‘x’) that appeared
at randomly varying intervals on a display screen. The
task measures included the median reaction time, stan-
dard deviation of the reaction time, omission errors (misses),
and commission errors (false alarms).
Blood samples
To determine the individual concentrations of TRP, TYR,
and PHE, several blood samples were obtained at different
time points. One blood sample was obtained under base-
line conditions, and an additional blood sample (T2) was
obtained after the MRI experiment (approximately 360
min after the challenge intake) to quantify the amount
of depletion after the challenge (ATD/PTD) or control
(BAL) administration.
All blood samples were obtained and treated as follows:
after 30 min of clotting time, the blood was centrifuged at
2,500 rtb for 10 min, pipetted into crya vials, and retained
in a freezer at 808C until final analysis. All samples
were measured and evaluated for the concentrations of
TRP, PHE, TYR and competing branched chained amino
acids (BCAAs). The method for the measurement of
TRP, PHE, and TYR concentrations was an immunosor-
bent assay (ELISA) kit (Immundiagnostik AG, Bensheim,
Germany), which was used in accordance with the manu-
facturer’s instructions. The BCAA concentrations were
determined using a commercially available enzyme BCAA
test kit (Immundiagnostik AG, Bensheim, Germany).
Statistical analysis
Statistical evaluation of the data was performed using
SPSS 20 software (IBM Statistics). The potential group
differences were analyzed using KruskalWallis tests with
‘challenge administration’ as a between-group factor and
reaction times for each run of the task as a dependent
variable. To study the impact of dietary depletion strate-
gies on reaction times, the differences in concentrations
Table 2. The amino acid quantities (amount per 10 kg body weight)
for the challenge conditions, including acute tryptophan depletion
(ATD, to decrease central nervous system serotonin synthesis),
phenylalaninetyrosine depletion (PTD, to decrease central nervous
system dopamine synthesis), and a balanced amino acid load (BAL,
which serves as a control condition)
Amino acids ATD (g) PTD (g) BAL (g)
L-Phenylalanine 1.32  1.32
L-Leucine 1.32 1.32 1.32
L-Isoleucine 0.84 0.84 0.84
L-Methionine 0.5 0.5 0.5
L-Valine 0.96 0.96 0.96
L-Threonine 0.6 0.6 0.6
L-Lysine-HCl
(L-Lysine 0.9 g/10 kg)
1.2 1.2 1.2
L-Tryptophan  0.7 0.7
Phasic alertness in healthy adults
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for each relevant AA before and after challenge admin-
istration in relation to the differences in the competing
AAs before and after depletion were calculated as an
index of the depletion magnitude [TRP ratio]: (TRPT1/
BCAAT1PHET1TYRT1)-(TRPT2/BCAAT2PHET2
TYRT2); TYR ratio: (TYRT1/BCAAT1PHET1TRPT1)-
(TYRT2/BCAAT2PHET2TRPT2); PHE ratio: (PHET1/
BCAAT1TRPT1TYRT1)-(PHET2/BCAAT2TRPT2
TYRT2). Using a group-wise dimensional approach, a
Spearman rho correlation was conducted for each group
to identify significant correlations between the depletion
magnitude and median reaction times (RTmdn) of the
phasic alertness task.
In addition to the RTmdn, the alertness reaction, which
indicates increasing levels of attention, was assessed using
t-values for PA that were assessed within the previously
described testing battery; it was defined as the subject’s
ability to shorten their own reaction times in trials in
which the relevant stimulus was preceded by a signal tone
(runs two and three). The level of statistical significance
was set at pB0.05. Because of the explorative nature of
this study and to not overlook significant relationships,
this study did not incorporate alpha-adjustment. As an
estimate of the relevant effect sizes, Cohen’s d values were
calculated. This study was conducted as a pilot in order
to generate first data that allows for the calculation of
sample sizes for future large-scale research. As for pilot
studies power calculations are not an essential criterion, a
post-hoc power analysis was conducted using StatMate
(GraphPad, La Jolla, USA) for the calculation of sample
sizes of such future studies.
Results
Neurochemical effects of the challenge administration
In the assessment of the TRP-, PHE-, and TYR-ratios at
T2, a KruskalWallis test identified a significant effect
for the factor challenge administration (TRP ratio:
p0.000, x236.14, df2, 47; PHE ratio: p0.000,
x233.13, df2, 47; and TYR ratio: p0.000, x2
34.26, df2, 47). In particular, for T2 after ATD
administration, a WilcoxonMannWhitney test demon-
strated that the TRP ratio (p0.000, U0, T136),
PHE ratio (p0.589, U121, T274), and TYR ratio
(p0.031, U76, T229) were significantly different
than for BAL administration. With regard to the PTD
challenge, similar results were identified with respect to
the TRP ratio (p0.000, U58, T211), PHE ratio
(p0.000, U0, T153), and TYR ratio (p0.000,
U4, T157) compared with BAL administration.
Overall, these findings demonstrate that the depletion
strategies used with regard to 5-HT (ATD) and DA
(PTD) worked as intended. Moreover, there were no
significant differences between the ATD, PTD, and BAL
groups at baseline regarding the TRP ratio (p0.29,
x22.46, df2, 47), PHE ratio (p0.59, x21.07,
df2, 47), or TYR ratio (p0.79, x20.47, df2, 47).
An overview of these findings is provided in Fig. 1a and b.
Effects of the challenge administration on phasic alertness
The median of the reaction time (RTmdn) is a measure of
general slowdown, whereas the standard deviation of the
reaction time is indicative of fluctuations in attentional
performance.
No significant differences regarding the t-values
for phasic alertness or RTmdn for the different dietary
challenge conditions (ATD/PTD/BAL) were identified
(Table 3).
Effects of depletion magnitude on RTmdn
A dimensional analysis indicated a significant positive
correlation between the reaction times and the DA-related
depletion magnitude. The lower the TYR concentration
was (which equaled a stronger depletion magnitude), the
slower reaction times for the first run of the task were for
the participants who received the PTD challenge (r0.534,
p0.027, Fig. 2); the Cohen’s d value of ]1 indicated a
medium to large estimated effect (41). For the remaining
runs, no significant associations between the TYR concen-
trations and reaction times were identified in the same
group. A higher TRP concentration in the same challenge
group (PTD) was associated with a slower reaction time in
the fourth run of the task, which also had a medium to
large estimated effect size (r0.533, p0.027, Cohen’s
d]1, Fig. 3). However, the remaining runs exhibited no
BAL
Challenge administration
AA
 ra
tio
ATD PTD
0.00
0.05
0.10
0.15
TRP-ratio
PHE-ratio
TYR-ratio
BAL
Challenge administration
AA
 ra
tio
ATD PTD
0.0
0.1
0.2
0.3
TRP-ratio
PHE-ratio
TYR-ratio
(a)
(b)
Fig. 1. (a) The respective AA ratios prior to challenge
administration. (b) The respective AA ratios after challenge
administration.
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significant relationships between the TRP concentrations
and the reaction times in the PTD group.
Regarding statistical power, based on the data ob-
tained in the present investigation, to detect an average
significant difference in means (t-values for phasic alertness)
of 0.089 between the ATD and BAL groups with an
alpha-level of 0.05 (two-tailed, unpaired t-test), a power
of 95% was calculated. However, the difference identified
in the present sample was 0.020. Regarding the compar-
ison of the PTD and BAL groups, to detect an average
significant difference in the means (t-values for phasic
alertness) of 0.085 between the PTD and BAL groups
with an alpha-level of 0.05 (two-tailed, unpaired t-test), a
power of 95% was calculated; however, the difference
observed was 0.04. Thus, future studies must include
substantially larger samples. This pilot study provides an
estimate for the calculation of sample sizes for future
large-scale research.
Discussion
In the present study, no significant group differences were
identified. However, a dimensional analysis indicated that
in the PTD challenge group, lower TYR concentrations
as a surrogate for decreased DA-related precursor avail-
ability were correlated with slower reaction times in the
first run of the task. In contrast, a higher TRP con-
centration in the same group was correlated with a slower
reaction time in the fourth run of the task, whereas other
runs of the task did not exhibit this association. Overall,
the study findings are largely negative, which could be
because of the sample size, as supported by the data
obtained from the post-hoc power analysis. However, the
lack of differences in alertness performance between the
three challenge groups could also be because of func-
tional and intact compensation mechanisms. This con-
cept appears plausible from biological and, in part,
genetic viewpoints because none of the subjects had a
personal or family history of a psychiatric disorder, which
has been shown to influence mood, motivational pro-
cesses and neural reward pathways after monoamine
depletion (4245). Moreover, phasic alertness is one
of the most basic aspects of human attention. A basic
requirement of such important and basic functions is
stability against external effects. Changes in the plasma
Table 3. The values for the mean reaction times and the statistics (KruskalWallis test) for each run of the task, the trials with and without a
signal tone, and the t-values of phasic alertness
Kruskal  Wallis test
df p-value Chi-squared values Mean  ATD Mean  PTD Mean  BAL
t-values for phasic alertness 2, 47 0.8 0.73 0.0390.07 0.0190.05 0.0490.08
Reaction times run 1 2, 47 0.4 1.84 240.69928.23 228.06925.84 234.41933.61
Reaction times run 2 2, 47 0.77 0.52 234.56926.03 230.76925.74 229.29925.13
Reaction times run 3 2, 47 0.39 1.88 238.38927.46 228.41922.97 224.88922.1
Reaction times run 4 2, 47 0.49 1.43 249.06934.36 236.12930.65 240.29927.9
Reaction times without a signal tone 2, 47 0.39 1.86 245.63930.02 232.35926.74 237.35927.47
Reaction times with a signal tone 2, 47 0.57 1.12 236.06925.35 229.29922.56 226.82920.8
Fig. 2. Correlation between plasma TYR-ratio and the median reaction time (milliseconds) in the first run of the task in the
PTD-challenge group (p0.027, r0.534).
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TRP ratio occurring after a carbohydrate-rich meal may
slightly modify 5-HT synthesis. However, an increase in
circulating TRP in the periphery cannot be equated to
equivalent changes in brain TRP concentrations, in par-
ticular because brain TRP availability depends on the
ratio of TRP to LNAAs. Factors possibly influencing TRP
supply are therefore frequency, size, and composition of
meals ingested and the resultant insulin secretion (of
note, no subject had diabetes, and all subjects partici-
pated after an overnight protein fast and also had a
standardized breakfast, which is a standard procedure in
ATD-related research).
Attentional performance is somewhat more vulnerable
to dietary depletion of DA, whereas 5-HT is more
responsible for impulsive behavior (46). There is evidence
that the ascending serotonergic system has inhibitory
effects on other monoamine and cholinergic neurotrans-
mitter systems, in particular, regarding behavioral inhibi-
tion and cortical de-arousal (30). Similar to DA, 5-HT
plays an important role in many physiological functions.
Hence, 5-HT depletion may improve attentional control
in the short term. This particular finding could explain
the identified correlation between TRP and RTmdn in
the PTD group, with the elevated TRP concentrations
serving as a potential cause of the slower reaction times.
However, higher TRP concentrations cannot be the
sole explanation for the slower reaction times identified
because they cannot explain the negative findings in the
balanced group with similar TRP concentrations after
AA ingestion. These observations could be explained
through a declined SNR in the participants of the PTD-
challenge group. In particular, DA optimizes signal
processing via the augmentation of the SNR (23, 24).
Mehta et al. demonstrated that MPH may have improved
response to signals with concomitant suppression of
background noise and thereby improved the task results
of participants, which depended on the individual base-
line levels in the task (47). Although DA and 5-HT have
distinct and even partially opposed functions regarding
attentional control, both systems significantly interact
because their functions in prefrontal cortical networks
are inextricably related (48). The interactions between
these two neurotransmitter systems have been empha-
sized in several other studies. Harrison demonstrated that
increased impulsiveness in 5-HT-depleted rats, which was
caused by brain lesions, was blocked through the admin-
istration of a D1-receptor antagonist (49). Regarding the
detected preliminary associations, if these findings are
replicated in larger studies, the findings of the present
study together with previous research may suggest that
short-term decreases in the synthesis rates of central
nervous system DA and 5-HT, which are achieved by
dietary depletion strategies, lead to dysfunctional inter-
actions between these two ascending neurochemical
systems.
The dietary depletion challenge administration (ATD,
PTD) resulted in significantly lowered TRP, PHE, and
TYR concentrations and TRP, PHE, and TYR ratios,
respectively. ATD decreased the TRP ratio by 65%,
whereas PTD lowered the PHE ratio by 65% and the
TYR ratio by 82%. Overall, these data indicate that the
neurochemical depletion paradigms had the intended
effect. Recent studies in mice that used the same Moja-
De AA-mixtures as humans confirmed the reduced brain
5-HT and DA synthesis after challenge administration (1,
35). Moreover, indirect evidence originates from studies in
humans that used plasma concentrations of relevant AAs
(3, 7, 10, 29, 34), the prolactin response to fenfluramine
administration (50) or corresponding metabolites (9) as
markers for successful depletion. It must be mentioned
that in the past, multiple and quite diverse dietary deple-
tion formulas have been used to alter serotonergic and
Fig. 3. Correlation between plasma TRP-ratio and the median reaction time (milliseconds) in the fourth run of the
PTD-challenge group (p0.027, r0.533).
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dopaminergic neurotransmission, which complicates a
detailed comparison (3, 5, 6, 8, 10, 28, 29, 34, 51).
Furthermore, PTD-treated mice exhibited changes in
brain TRP in the frontal cortex compared with the BAL
condition (35). These results are of particular importance
specifically because prefrontal cortical functions play
a major role in attentional control, which is mediated
through the ascending dopaminergic and serotoninergic
projections (46).
Deficiencies in attentional control, motivational pro-
cesses, memory, and behavioral processes are present in
different clinical populations, such as in patients with
ADHD. The present study is the first study to identify
preliminary data that indicates lower plasma TYR levels
after PTD were correlated with slower reaction times in
specific runs of the task used. A decrease in reaction time
tasks has been demonstrated in previous research using
dietary depletion of TYR and PHE to attenuate central
nervous system DA function, which suggests a role for
DA in motor readiness and other cognitive functions (30).
Further work has identified baseline-dependent improve-
ments in cognitive function after the administration of
D1 receptor agonists in rats (with individual differences
in performance) (52). With regard to a review of the
effects of ATD administration on memory, attention, and
executive functions, our findings are somewhat con-
flicting because no effect of dietary ATD administration
on sustained or divided attention was identified (27). In
contrast, it was shown that involuntary attention shifting
was altered after ATD administration, which was indexed
by effects on EEG data (53).
Increased TRP influx across bloodbrain barrier can be
observed after both BAL and PTD challenges (3, 35). An
effective TRP-loading can be achieved with doses of TRP
in relation to the competing AAs and an even lower dose
than used in this study (5456). Overall, if confirmed by
future larger studies, the preliminary results from the
dimensional analysis could suggest that in subjects with an
altered DA synthesis, TRP loading may positively affect
attentional control. However, at this stage, this finding
remains speculative and must be further investigated.
Some advantages of this study should be highlighted.
The dietary depletion method (Moja-De) used is advanta-
geous because of its acceptable tolerability, which enables
its use even in children and adolescents (12, 29, 34, 57).
The body weightadapted dosing is likely to reduce side
effects without affecting the depletion magnitude, which
has been demonstrated in rodents and humans. As ex-
pected, depletion resulted in significantly lowered TRP,
PHE, and TYR concentrations.
The present study also has several limitations. The
limited sample size and the between-subjects design must
be considered confounders. Moreover, the challenge con-
ditions (ATD and PTD) used are thought to affect the
whole brain, which raises the likely problem of regional
differences in ATD and PTD induced changes in central
nervous system neurotransmitter synthesis. Using the
outlined depletion paradigms, it is not possible to eluci-
date specific dopaminergic or serotonergic functions
related to different brain regions and isolated neurocir-
cuits. Depletion may vary from one brain region to
another region (58, 59). Studies that combine functional
neuroimaging techniques and depletion and other neuro-
chemical concepts are of particular value to examine the
impact of different neurotransmitters in healthy and
vulnerable populations regarding different brain regions
(58, 59).
To our knowledge, this is the first study to investigate
the effects of dietary ATD and PTD administration on
phasic alertness in healthy adult volunteers. Overall, the
results were primarily negative. However, if confirmed by
future research, the results of the conducted dimensional
analysis of the present pilot study may support the com-
plex nature of serotonergic and dopaminergic interactions
in the regulation of phasic alertness, which may have impli-
cations for the better understanding, and consequently,
treatment of neuropsychiatric disorders related to mono-
aminergic dysfunctions. Future research with larger sam-
ples is necessary to further disentangle the relationship
between the central nervous system availability of 5-HT
and DA, with the potential use of dietary depletion pro-
tocols that aim to alter neurotransmitter synthesis with
regard to related dietary precursor availability.
Conflict of interest and funding
This study was funded by the Excellence Initiative of
the German federal and state governments. FDZ was
the recipient of an unrestricted award donated by the
American Psychiatric Association (APA), the American
Psychiatric Institute for Research and Education
(APIRE), and AstraZeneca (Young Minds in Psychiatry
Award). He has also received research support from the
European Union, the German Federal Ministry for
Economics and Technology, the German Society for
Social Pediatrics and Adolescent Medicine, the Paul and
Ursula Klein Foundation, the Dr. August Scheidel
Foundation and the IZKF of RWTH Aachen University
and a travel stipend donated by the GlaxoSmithKline
Foundation. He is the recipient of an unrestricted
educational grant, travel support and speaker honoraria
by Shire Pharmaceuticals, Germany, as well as editorial
fees from Co-Action Publishing (Sweden). In addition, he
has received support from the Raine Foundation for
Medical Research (Raine Visiting Professorship). GRF
serves as an editorial board member of Cortex, Neuro-
Image: Clinical, Zeitschrift fu¨r Neuropsychologie and
Fortschritte der Neurologie Psychiatrie; receives royalties
from the publication of the book Funktionelle MRT
in Psychiatrie und Neurologie and Neurologische
Phasic alertness in healthy adults
Citation: Food & Nutrition Research 2015, 59: 26407 - http://dx.doi.org/10.3402/fnr.v59.26407 9
(page number not for citation purpose)
Differentialdiagnose; received honoraria for speaking
engagements from TEVA, GlaxoSmith-Kline, Bayer,
Desitin, Infoforum and Boehringer Ingelheim; and
received or receives research support from the Bundesmi-
nisterium fu¨r Bildung und Forschung and the Deutsche
Forschungsgemeinschaft. The other authors (PH, WK,
TJG, SBB, KH, CSB, KJL) have nothing to disclose or
report.
References
1. Biskup CS, Sanchez CL, Arrant A, Van Swearingen AE, Kuhn
C, Zepf FD. Effects of acute tryptophan depletion on brain
serotonin function and concentrations of dopamine and nor-
epinephrine in C57BL/6J and BALB/cJ mice. PLoS One 2012; 7:
e35916.
2. Demisch L, Kewitz A, Schmeck K, Sadigorsky S, Barta S,
Dierks T, et al. Methodology of rapid tryptophan depletion
(RTD): impact of gender and body weight. Eur Arch Psychiatry
Clin Neurosci 2002; 252: I/25.
3. Dingerkus VL, Gaber TJ, Helmbold K, Bubenzer S, Eisert A,
Sanchez CL, et al. Acute tryptophan depletion in accordance
with body weight: influx of amino acids across the bloodbrain
barrier. J Neural Transm 2012; 119: 103745.
4. Gessa GL, Biggio G, Fadda F, Corsini GU, Tagliamonte A.
Effect of the oral administration of tryptophan-free amino acid
mixtures on serum tryptophan, brain tryptophan and serotonin
metabolism. J Neurochem 1974; 22: 86970.
5. Harmer CJ, McTavish SF, Clark L, Goodwin GM, Cowen PJ.
Tyrosine depletion attenuates dopamine function in healthy
volunteers. Psychopharmacology 2001; 154: 10511.
6. Leyton M, Young SN, Pihl RO, Etezadi S, Lauze C, Blier P,
et al. A comparison of the effects of acute tryptophan depletion
and acute phenylalanine/tyrosine depletion in healthy women.
Adv Exp Med Biol 1999; 467: 6771.
7. Mehta MA, Gumaste D, Montgomery AJ, McTavish SF,
Grasby PM. The effects of acute tyrosine and phenylalanine
depletion on spatial working memory and planning in healthy
volunteers are predicted by changes in striatal dopamine levels.
Psychopharmacology 2005; 180: 65463.
8. Moja EA, Stoff DM, Gessa GL, Castoldi D, Assereto R,
Tofanetti O. Decrease in plasma tryptophan after tryptophan-
free amino acid mixtures in man. Life Sci 1988; 42: 15516.
9. Reilly JG, McTavish SF, Young AH. Rapid depletion of plasma
tryptophan: a review of studies and experimental methodology.
J Psychopharmacol 1997; 11: 38192.
10. Scholes KE, Harrison BJ, O’Neill BV, Leung S, Croft RJ,
Pipingas A, et al. Acute serotonin and dopamine depletion
improves attentional control: findings from the stroop task.
Neuropsychopharmacology 2007; 32: 160010.
11. Zepf FD, Holtmann M, Stadler C, Magnus S, Wockel L,
Poustka F. Diminished central nervous 5-HT neurotransmis-
sion and mood self-ratings in children and adolescents with
ADHD: no clear effect of rapid tryptophan depletion. Hum
Psychopharmacol 2009; 24: 8794.
12. Zepf FD, Landgraf M, Biskup CS, Dahmen B, Poustka F,
Wockel L, et al. No effect of acute tryptophan depletion on
verbal declarative memory in young persons with ADHD. Acta
Psychiatr Scand 2013; 128: 13341.
13. Petersen SE, Posner MI. The attention system of the human
brain: 20 years after. Annu Rev Neurosci 2012; 35: 7389.
14. Cowan N. Evolving conceptions of memory storage, selective
attention, and their mutual constraints within the human
information-processing system. Psychol Bull 1988; 104: 16391.
15. Posner MI, Petersen SE. The attention system of the human
brain. Annu Rev Neurosci 1990; 13: 2542.
16. Duncan J. The locus of interference in the perception of
simultaneous stimuli. Psychol Rev 1980; 87: 272300.
17. Posner MI, Boies SJ. Components of attention. Psychol Rev
1971; 78: 391408.
18. Perin B, Godefroy O, Fall S, de Marco G. Alertness in young
healthy subjects: an fMRI study of brain region interactivity
enhanced by a warning signal. Brain Cogn 2010; 72: 27181.
19. Bush G, Luu P, Posner MI. Cognitive and emotional influences
in anterior cingulate cortex. Trends Cogn Sci 2000; 4: 21522.
20. Bush G, Frazier JA, Rauch SL, Seidman LJ, Whalen PJ, Jenike
MA, et al. Anterior cingulate cortex dysfunction in attention-
deficit/hyperactivity disorder revealed by fMRI and the Count-
ing Stroop. Biol Psychiatry 1999; 45: 154252.
21. Sturm W, Willmes K. On the functional neuroanatomy of
intrinsic and phasic alertness. Neuroimage 2001; 14: S7684.
22. Fan J, Fossella J, Sommer T, Wu Y, Posner MI. Mapping the
genetic variation of executive attention onto brain activity. Proc
Natl Acad Sci USA 2003; 100: 740611.
23. Winterer G, Weinberger DR. Genes, dopamine and cortical
signal-to-noise ratio in schizophrenia. Trends Neurosci 2004; 27:
68390.
24. Kroener S, Chandler LJ, Phillips PE, Seamans JK. Dopamine
modulates persistent synaptic activity and enhances the signal-
to-noise ratio in the prefrontal cortex. PLoS One 2009; 4: e6507.
25. Robbins TW. Chemical neuromodulation of frontal-executive
functions in humans and other animals. Exp Brain Res 2000;
133: 1308.
26. Green AE, Munafo MR, DeYoung CG, Fossella JA, Fan J,
Gray JR. Using genetic data in cognitive neuroscience: from
growing pains to genuine insights. Nat Rev Neurosci 2008; 9:
71020.
27. Mendelsohn D, Riedel WJ, Sambeth A. Effects of acute
tryptophan depletion on memory, attention and executive
functions: a systematic review. Neurosci Biobehav Rev 2009;
33: 92652.
28. Schmitt JA, Jorissen BL, Sobczak S, van Boxtel MP, Hogervorst
E, Deutz NE, et al. Tryptophan depletion impairs memory
consolidation but improves focussed attention in healthy young
volunteers. J Psychopharmacol 2000; 14: 219.
29. Zepf FD, Gaber TJ, Baurmann D, Bubenzer S, Konrad K,
Herpertz-Dahlmann B, et al. Serotonergic neurotransmission
and lapses of attention in children and adolescents with
attention deficit hyperactivity disorder: availability of trypto-
phan influences attentional performance. Int J Neuropsycho-
pharmacol 2010; 13: 93341.
30. Robbins TW. Arousal systems and attentional processes. Biol
Psychol 1997; 45: 5771.
31. Nieoullon A. Dopamine and the regulation of cognition and
attention. Prog Neurobiol 2002; 67: 5383.
32. Zepf FD. Untersuchung zentralnervo¨ser serotonerger Funktio-
nen mit Hilfe des »Rapid Tryptophan Depletion-Test« (RTD)
bei ma¨nnlichen Kindern und Jugendlichen mit Aufmerksam-
keits-Defizit/Hyperaktivita¨ts Syndrom (ADHS). Germany: Tec-
tum Verlag Marburg; 2008, 150 p.
33. Kotting WF, Bubenzer S, Helmbold K, Eisert A, Gaber TJ, Zepf
FD. Effects of tryptophan depletion on reactive aggression and
aggressive decision-making in young people with ADHD. Acta
Psychiatr Scand 2013; 128: 11423.
34. Zepf FD, Stadler C, Demisch L, Schmitt M, Landgraf M,
Poustka F. Serotonergic functioning and trait-impulsivity in
attention-deficit/hyperactivity-disordered boys (ADHD): influ-
ence of rapid tryptophan depletion. Hum Psychopharmacol
2008; 23: 4351.
Patricia Hildebrand et al.
10
(page number not for citation purpose)
Citation: Food & Nutrition Research 2015, 59: 26407 - http://dx.doi.org/10.3402/fnr.v59.26407
35. Sanchez CL, Van Swearingen AE, Arrant AE, Kuhn CM, Zepf
FD. Dietary manipulation of serotonergic and dopaminergic
function in C57BL/6J mice with amino acid depletion mixtures.
J Neural Transm 2014; 121: 15362.
36. Markus CR. Dietary amino acids and brain serotonin function;
implications for stress-related affective changes. Neuromol Med
2008; 10: 24758.
37. Carlsson A, Lindqvist M. Dependence of 5-HT and catechola-
mine synthesis on concentrations of precursor amino-acids in
rat brain. Naunyn Schmiedebergs Arch Pharmacol 1978; 303:
15764.
38. Jakeman PM. Amino acid metabolism, branched-chain amino
acid feeding and brain monoamine function. Proc Nutr Soc
1998; 57: 3541.
39. Dalbert C. Young adults’ subjective well-being: theoretical and
empirical analyses of its structure and stability. Zeitschrift fu¨r
Differentielle und Diagnostische Psychologie 1992; 13: 20720.
40. Zimmermann PF, Bruno. Testbatterie zur Aufmerksamkeitspru¨-
fung: (TAP), Version 1.72002.
41. Cohen JD. Statistical power analysis for the behavioral sciences.
2nd ed. Hillsdale: Lawrence Erlbaum Associates; 1988.
42. Ruhe HG, Mason NS, Schene AH. Mood is indirectly related to
serotonin, norepinephrine and dopamine levels in humans: a
meta-analysis of monoamine depletion studies. Mol Psychiatry
2007; 12: 33159.
43. Roiser JP, Blackwell AD, Cools R, Clark L, Rubinsztein DC,
Robbins TW, et al. Serotonin transporter polymorphism
mediates vulnerability to loss of incentive motivation following
acute tryptophan depletion. Neuropsychopharmacology 2006;
31: 226472.
44. Rocha BA, Scearce-Levie K, Lucas JJ, Hiroi N, Castanon N,
Crabbe JC, et al. Increased vulnerability to cocaine in mice
lacking the serotonin-1B receptor. Nature 1998; 393: 1758.
45. Booij L, Van der Does AJ, Riedel WJ. Monoamine depletion in
psychiatric and healthy populations: review. Mol Psychiatry
2003; 8: 95173.
46. Robbins TW. Chemistry of the mind: neurochemical modula-
tion of prefrontal cortical function. J Comp Neurol 2005; 493:
1406.
47. Mehta MA, Owen AM, Sahakian BJ, Mavaddat N, Pickard JD,
Robbins TW. Methylphenidate enhances working memory by
modulating discrete frontal and parietal lobe regions in the
human brain. J Neurosci 2000; 20: RC65.
48. Goldman-Rakic PS. The prefrontal landscape: implications of
functional architecture for understanding human mentation and
the central executive. Philos Trans R Soc Lond B Biol Sci 1996;
351: 144553.
49. Harrison AA, Everitt BJ, Robbins TW. Central 5-HT depletion
enhances impulsive responding without affecting the accuracy
of attentional performance: interactions with dopaminergic
mechanisms. Psychopharmacology 1997; 133: 32942.
50. Evans J, Platts H, Lightman S, Nutt D. Impulsiveness and
the prolactin response to d-fenfluramine. Psychopharmacology
2000; 149: 14752.
51. Fernstrom JD, Wurtman RJ, Hammarstrom-Wiklund B, Rand
WM, Munro HN, Davidson CS. Diurnal variations in plasma
concentrations of tryptophan, tryosine, and other neutral amino
acids: effect of dietary protein intake. Am J Clin Nutr 1979; 32:
191222.
52. Granon S, Passetti F, Thomas KL, Dalley JW, Everitt BJ,
Robbins TW. Enhanced and impaired attentional performance
after infusion of D1 dopaminergic receptor agents into rat
prefrontal cortex. J Neurosci 2000; 20: 120815.
53. Ahveninen J, Kahkonen S, Pennanen S, Liesivuori J, Ilmoniemi
RJ, Jaaskelainen IP. Tryptophan depletion effects on EEG
and MEG responses suggest serotonergic modulation of audi-
tory involuntary attention in humans. Neuroimage 2002; 16:
105261.
54. Luciana M, Burgund ED, Berman M, Hanson KL. Effects of
tryptophan loading on verbal, spatial and affective working
memory functions in healthy adults. J Psychopharmacol 2001;
15: 21930.
55. Bjork JM, Dougherty DM, Moeller FG, Cherek DR, Swann
AC. The effects of tryptophan depletion and loading on
laboratory aggression in men: time course and a food-restricted
control. Psychopharmacology 1999; 142: 2430.
56. Glass JD, Selim M, Srkalovic G, Rea MA. Tryptophan loading
modulates light-induced responses in the mammalian circadian
system. J Biol Rhythms 1995; 10: 8090.
57. Helmbold K, Bubenzer S, Dahmen B, Eisert A, Gaber TJ,
Habel U, et al. Influence of acute tryptophan depletion on
verbal declarative episodic memory in young adult females.
Amino Acids 2013; 45: 120719.
58. Biskup CS, Gaber TJ, Helmbold K, Bubenzer-Busch S, Zepf
FD. Amino acid challenge and depletion techniques in human
functional neuroimaging studies: an overview. Amino Acids
2015; 47: 65183.
59. Helmbold K, Zvyagintsev M, Dahmen B, Bubenzer-Busch S,
Gaber TJ, Crockett MJ, et al. Effects of serotonin depletion on
punishment processing in the orbitofrontal and anterior cingu-
late cortices of healthy women. Eur Neuropsychopharmacol
2015; pii: S0924-977X(15)00040-1. doi: 10.1016/j.euroneuro.2015.
02.007.
*Florian Daniel Zepf
Department of Child and Adolescent Psychiatry
The University of Western Australia (M561)
35 Stirling Highway, Crawley, WA 6009, Perth, Australia
Email: florian.zepf@uwa.edu.au
Phasic alertness in healthy adults
Citation: Food & Nutrition Research 2015, 59: 26407 - http://dx.doi.org/10.3402/fnr.v59.26407 11
(page number not for citation purpose)
